ELEVAI LABS Presented On Exosome Technology at Octane Aesthetics Tech Forum

ELEVAI LABS Presented On Exosome Technology at Octane Aesthetics Tech Forum
ELEVAI LABS retuned to the Octane Aesthetics Tech Forum to participate in the panel, “Unmet Innovations in Medical Aesthetics."
Photo courtesy of ELEVAI LABS

ELEVAI LABS retuned to the Octane Aesthetics Tech Forum on Jan. 27, 2023 at the Balboa Bay Resort in New Port Beach, CA. Known for fueling innovation in the aesthetic industry, the forum was a curation of ideas, experts, startups and education. 

ELEVAI participated in the panel, “Unmet Innovations in Medical Aesthetics." Brenda Buechler, ELEVAI Labs’ Chief Marketing Officer, discussed advancing aesthetic technology, leveraging the power of patent pending ELEVAI ExosomesTM and its nanotechnology for skin repair and rejuvenation.

Related: ELEVAI Unveils Exosome Technology at Global Aesthetics Conference

The two-day summit united leaders in the medicine, industry and the business world to discuss medical aesthetic technologies, as well as unmet clinical needs and business opportunities. ELEVAI's co-founder, Jordan R. Plews, Ph.D., gave an award winning presentation at the 2022 event, which was honored as that year's People's Choice Award winner by plastic surgeons, dermatologists and industry leaders. 

“We were honored to return to Octane Aesthetics Tech Forum to share with colleagues and other industry innovators how ELEVAI is leading the way in regenerative aesthetics with our science-first skin care product line," said Plews.

Octane also recognized ELEVAI as a top medical aesthetics innovator and selected the company for its LaunchPad Small Business Development Center (“SBDC”) business accelerator, a program developed to help companies seeking Series A funding, which ultimately raised a combined total of $50 million among participants.

More in Event Coverage